Therapeutic plasma exchange and intravenous immune globulin in the treatment of heparin‐induced thrombocytopenia: A systematic review-Reference-Cited by-同舟云学术

Therapeutic plasma exchange and intravenous immune globulin in the treatment of heparin‐induced thrombocytopenia: A systematic review

Published:2020-08-19 Issue:11 Volume:60 Page:2714-2736
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Onuoha Chinonso¹,Barton Karen D.²,Wong Edward C.C.³⁴,Raval Jay S.⁵,Rollins‐Raval Marian A.⁵,Ipe Tina S.⁶,Kiss Joseph E.⁷,Boral Leonard I.⁸,Adamksi Jill⁹^ORCID,Zantek Nicole D.¹⁰,Onwuemene Oluwatoyosi A.¹¹^ORCID

Affiliation:

1. Department of Pediatrics East Carolina University, Vidant Medical Center Greenville North Carolina USA

2. Medical Center Library Duke University Medical Center Durham North Carolina USA

3. Department of Pediatrics and Pathology George Washington School of Medicine and Health Sciences Washington, DC USA

4. Department of Coagulation Quest Diagnostics, Nichols Institute Centreville Virginia USA

5. Department of Pathology University of New Mexico Albuquerque New Mexico USA

6. Department of Pathology and Laboratory Medicine University of Arkansas for Medical Sciences Little Rock Arkansas USA

7. Department of Medicine Vitalant Northeast Division and The University of Pittsburgh Pittsburgh Pennsylvania USA

8. Department of Pathology and Laboratory Medicine University of Kentucky Health Care Lexington Kentucky USA

9. Department of Laboratory Medicine and Pathology Mayo Clinic Arizona Phoenix Arizona USA

10. Department of Laboratory Medicine and Pathology University of Minnesota Minneapolis Minnesota USA

11. Department of Medicine Duke University School of Medicine Durham North Carolina USA

Funder

Hemostasis and Thrombosis Research Society

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.16018

Reference77 articles.

1. FcγRIIA H/R131 Polymorphism, Subclass-Specific IgG Anti-Heparin/Platelet Factor 4 Antibodies and Clinical Course in Patients With Heparin-Induced Thrombocytopenia and Thrombosis

2. Clinical outcomes in a cohort of patients with heparin-induced thrombocytopenia

3. Disease burden, complication rates, and health-care costs of heparin-induced thrombocytopenia in the USA: a population-based study

4. Impact of Heparin-Induced Thrombocytopenia on Postoperative Outcomes After Cardiac Surgery

5. Plasmapheresis and Heparin Reexposure as a Management Strategy for Cardiac Surgical Patients with Heparin-Induced Thrombocytopenia

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Therapeutic Plasma Exchange (TPE) or Cangrelor as an Adjunctive Strategy to Facilitate Cardiopulmonary Bypass in Patients with Heparin-induced Thrombocytopenia (HIT): a Systematic Review and Meta-analysis;Journal of Cardiothoracic and Vascular Anesthesia;2024-09

2. Consensus transfusion guidelines for a large neonatal intensive care network;Transfusion;2024-06-17

3. Apheresis Indications in the Perioperative Setting;Current Anesthesiology Reports;2024-06-15

4. Diagnosis and management of heparin‐induced thrombocytopenia: Third edition;British Journal of Haematology;2023-12-28

5. Perioperative Plasma Exchange and Intravenous Immunoglobulin Use for Refractory Heparin-Induced Thrombocytopenia in a Liver Transplant Recipient;American Journal of Case Reports;2023-12-20